SkyAI (SKYA) Proxy filing summary

Executive summary

• The annual meeting will be held virtually on September 18, 2026, to vote on director elections, auditor ratification, a new equity incentive plan, and potential adjournment if needed.

• The company has shifted from a medical device focus to a Digital Asset Treasury strategy, emphasizing long-term growth and disciplined capital allocation.

• Equity-based compensation is highlighted as a key tool for attracting and retaining talent while aligning interests with shareholders.

Voting matters and shareholder proposals

• Proposals include electing five directors, ratifying PKF O'Connor Davies, LLP as auditor, approving the 2026 Equity Incentive Plan, and authorizing adjournment if necessary.

• The board unanimously recommends voting FOR all proposals.

• Shareholders can vote online, by phone, or by mail, and may change their vote prior to or during the meeting.

Board of directors and corporate governance

• The board consists of five directors, with a majority classified as independent under Nasdaq rules.

• Committees include Audit, Compensation, Nominating and Governance, and Strategic Advisory, each with defined responsibilities and independent membership.

• The board met seven times in 2025, with high attendance from all directors.

• No family relationships exist among officers or directors; independence is regularly reviewed.